ClinicalTrials.gov
public full text
Public Domain
A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma
The primary objective of this study is to estimate the time to progressive disease for patients with advanced hepatocellular cancer who receive LY2181308.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)#1184488
- Additional file 1 of eGDR and gastrointestinal cancer mortality in the UK Biobank: a prospective cohort study#658819
- Liver Cancer Prognosis Investigation Study#858077
- A Study of LY2409021 in Patients With Type 2 Diabetes#249566
- Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer#1151045
Record · ID 1397084
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive